Thu, Aug 21, 2014, 11:20 AM EDT - U.S. Markets close in 4 hrs 40 mins

Recent

% | $
Quotes you view appear here for quick access.

Retrophin, Inc. Message Board

  • caffeinsomniac caffeinsomniac Jun 18, 2013 12:06 AM Flag

    SHORTED AT $6 FTW

    Mmmmmm... Made 4% on my short position in less than a day. This is going to be fun!!

    Sentiment: Strong Sell

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I actually don't think it's going to be fun for you. Maybe in the short term, but this stock is so thin, it will only take 1 serious buyer to push this back up to $8-9. I read your other posts and QCOR really has nothing to do with RTRX. So they were both bidding on the same drug and QCOR won. Who cares? This has no impact on the rest of Retrophin's business. Also, they have enough cash in the bank to get to FONT3 data. If the data are positive, they will be able to raise post-data at $10-15/share. But do whatever you want, I will be steadily buying this for the next 6 months or so.

      • 2 Replies to markak1515
      • $3.80 bids today!! Wheeeeee!!! This is fun!!! Don't say I didn't warn you.

        Sentiment: Strong Sell

      • Yeah, go ahead to short an illiquid stock. That will be the ticket for you buddy. I am not sure Martin thinks he can win the bid, nor I think he wants to get into the whole ACTH business in the cheap. But one thing he has accomplished by not spending a dime is to further the public awareness of the price hikes QCOR did - from a few hundred dollars per vial to over $28,000 each now. The FTC will have fun to look over the QCOR-NVS deal, regardless how it is structured. With the latest SCOTUS ruling on pay for play (Big pharma - generics deal), I would think a close examination of the QCOR-NVS deal is not that far fetch. Plus, do anyone think QCOR mgmt. want to get a high visibility discussion about its pricing strategy? If Martin was successful to grab the synthetic ACTH and sell it at a couple hundred bucks per vial, QCOR would be trading in the teens now. But then again, Martin wasn't successful with his bid, so, what's next with this drama? My bet is some FTC, DOJ noise ahead, and who knows, maybe they won't let the deal through at all; meanwhile, more people know about the pricing practices over QCOR.

 
RTRX
12.12-0.01(-0.08%)11:19 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.